logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Mototsugu Oya

keio university

61H-index
1.2KPaper Count
1.7WCitation Count
Published Papers 352
Publication Date
logo
A Case of Testicular Malakoplakia With Markedly High Signal Intensity on Fat-Suppressed T1-Weighted Images
errIJU Case Reports
IF0.6
err2026-04-27
err1
PREAI
errYagi, Fumiko; Akita, Hirotaka; Kosaka, Takeo; Ueno, Akihisa; Kotera, Teppei; Kobayashi, Masato; Mekada, Hideaki; Oya, Mototsugu; Jinzaki, Masahiro
errShare
errSave
Genomic alteration and clinical significance of circulating tumor DNA in patients with advanced urothelial cancer: SCRUM-Japan monstar screen project
errnpj Precision Oncology
IF8
err2025-11-18
err0
errOAAI
errTakahiro Osawa; Nobuaki Matsubara; Taigo Kato; Masaki Shiota; Koshiro Nishimoto; Takashige Abe; Nobuo Shinohara; Yota Yasumizu; Nobuyuki Tanaka; Mototsugu Oya; Hikaru Abutani; Takaaki Oda; Takao Fujisawa; Yoshiaki Nakamura; Smruthy Sivakumar; Masatoshi Eto; Takayuki Yoshino; Norio Nonomura
errShare
errSave
Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel Study
errEuropean Urology Oncology
IF9.3
err2025-11-17
err0
errOAAI
errAndrew J. Armstrong; Fred Saad; Mototsugu Oya; Karina Vianna; Mustafa Özgüroğlu; Craig Gedye; Gary L. Buchschacher; Ji Youl Lee; Urban Emmenegger; Jiří Navrátil; Juan Antonio Virizuela; Anibal Salazar; Denis Maillet; Hiroji Uemura; Christian Hosius; David McGuinness; Arnold Degboe; Noel Clarke
errShare
errSave
ASO Author Reflections: Advancing AI-Based Surgical Phase Recognition in Robot-Assisted Radical Prostatectomy
errAnnals of Surgical Oncology
IF3.5
err2025-11-13
err0
PREAI
errYuichiro Konnai; Keishiro Fukumoto; Masashi Takeuchi; Rei Takeuchi; Shinnosuke Fujiwara; Yota Yasumizu; Nobuyuki Tanaka; Toshikazu Takeda; Kazuhiro Matsumoto; Takeo Kosaka; Hirofumi Kawakubo; Yuko Kitagawa; Mototsugu Oya
errShare
errSave
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer
errEuropean Urology Oncology
IF9.3
err2025-11-04
err0
errOAAI
errFred Saad; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Emma Brown; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; Elizabeth A. Harrington; Jinyu Kang; Noel Clarke
errShare
errSave
Expression of Glucocorticoid Receptor and FOXO1/phospho-FOXO1 in Bladder Cancer as Independent Prognosticators
errCANCER GENOMICS & PROTEOMICS
IF2.6
err2025-11-01
err0
PREAI
errIde, Hiroki; Najafi, Mohammad Amin Elahi; Matsukawa, Takuo; Tatenuma, Tomoyuki; Oya, Mototsugu; Miyamoto, Hiroshi
errShare
errSave
GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab
errCancer Science
IF4.3
err2025-09-24
err0
errOAAI
errTokiyoshi Tanegashima; Masaki Shiota; Shusuke Akamatsu; Hideaki Miyake; Masayuki Takahashi; Mototsugu Oya; Norihiko Tsuchiya; Naoya Masumori; Hideyasu Matsuyama; Wataru Obara; Nobuo Shinohara; Kiyohide Fujimoto; Masahiro Nozawa; Kojiro Ohba; Chikara Ohyama; Katsuyoshi Hashine; Tomomi Kamba; Koji Mita; Momokazu Gotoh; Shuichi Tatarano; Masato Fujisawa; Yoshihiko Tomita; Shoichiro Mukai; Keiichi Ito; Shoji Tokunaga; Masatoshi Eto; SNiP-RCC investigators
errShare
errSave
Correction: Androgen receptor signaling induces hemorrhage and angiogenesis in the irradiated bladder
errScientific Reports
IF3.9
err2025-09-12
err0
errOAAI
errTakahiro Komori; Hiroki Ide; Junichi Fukada; Yuto Baba; Kazuhiro Matsumoto; Hiroshi Miyamoto; Mototsugu Oya
errShare
errSave
High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy (vol 23, pg 4115, 2016)
errANNALS OF SURGICAL ONCOLOGY
IF3.5
err2025-05-08
err0
PREAI
errShigeta, Keisuke; Kosaka, Takeo; Kitano, Shigehisa; Yasumizu, Yota; Miyazaki, Yasumasa; Mizuno, Ryuichi; Shinojima, Toshiaki; Kikuchi, Eiji; Miyajima, Akira; Tanoguchi, Hitoshi; Hasegawa, Shintaro; Oya, Mototsugu
errShare
errSave
Corrigendum to “Profiling FGFR3 Expression Based on the Immune Micro-environment in Upper Tract Urothelial Carcinoma” [Eur. Urol. Oncol. 7(6) (2024) 1338-1349]
errEuropean Urology Oncology
IF9.3
err2025-05-06
err0
errOAAI
errKeisuke Shigeta; Kazuhiro Matsumoto; Sotaro Kitaoka; Minami Omura; Kota Umeda; Yuki Arita; Shuji Mikami; Keishiro Fukumoto; Yota Yasumizu; Nobuyuki Tanaka; Toshikazu Takeda; Shinya Morita; Takeo Kosaka; Ryuichi Mizuno; Satoshi Hara; Mototsugu Oya
errShare
errSave
Adverse events of hepatic function disorder in Japanese patients with radically unresectable or metastatic renal cell carcinoma treated with pembrolizumab plus axitinib: a post-marketing surveillance study
errinternational journal of oncology
IF2.8
err2025-04-29
err0
errOAAI
errOya, Mototsugu; Yasuoka, Shotaro; Tokudome, Takuto; Minegishi, Toshihiko; Hamada, Masahiro; Ozaki, Masahiko; Maekawa, Shinichiroh; Ito, Yuichiro
errShare
errSave
Applicability of the regression approach for histological multi-class grading in clear cell renal cell carcinoma
errREGENERATIVE THERAPY
IF3.5
err2025-03-01
err0
PREAI
errShibata, Mayu; Umezawa, Akihiro; Aoto, Saki; Okamura, Kohji; Nasu, Michiyo; Mizuno, Ryuichi; Oya, Mototsugu; Yura, Kei; Mikami, Shuji
errShare
errSave
Real-world outcomes with avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification
errinternational journal of oncology
IF2.8
err2025-02-11
err0
errOAAI
errFurukawa, Junya; Kato, Taigo; Yamasaki, Toshinari; Monji, Keisuke; Tanaka, Toshiaki; Tsuchiya, Norihiko; Miyagawa, Tomoaki; Yaegashi, Hiroshi; Sano, Tomoyasu; Karashima, Takashi; Fujita, Kazutoshi; Hori, Jun-ichi; Ito, Takayuki; Kajita, Masahiro; Tomita, Yoshihiko; Shinohara, Nobuo; Eto, Masatoshi; Oya, Mototsugu; Uemura, Hirotsugu
errShare
errSave
Final Analysis of Post-Marketing Surveillance for Avelumab plus Axitinib in Patients With Renal Cell Carcinoma in Japan
errCANCER MEDICINE
IF3.1
err2025-01-21
err0
errOAAI
errNonomura, Norio; Ito, Taito; Sato, Masashi; Morita, Makiko; Ogi, Mie; Kajita, Masahiro; Oya, Mototsugu
errShare
errSave
Avelumab plus axitinib treatment in older patients with advanced renal cell carcinoma in Japan: Subgroup analyses of post-marketing surveillance data by age
errCANCER MEDICINE
IF3.1
err2025-01-21
err0
errOAAI
errOya, Mototsugu; Ito, Taito; Sato, Masashi; Morita, Makiko; Kajita, Masahiro; Nonomura, Norio
errShare
errSave
Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2024-12-01
err0
errOAAI
errShigeta, Keisuke; Matsumoto, Kazuhiro; Kitaoka, Sotaro; Omura, Minami; Umeda, Kota; Arita, Yuki; Mikami, Shuji; Fukumoto, Keishiro; Yasumizu, Yota; Tanaka, Nobuyuki; Takeda, Toshikazu; Morita, Shinya; Kosaka, Takeo; Mizuno, Ryuichi; Hara, Satoshi; Oya, Mototsugu
errShare
errSave
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial
errEuropean Urology Oncology
IF9.3
err2024-10-01
err0
errOAAI
errNoel W. Clarke; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Francis Parnis; Emma Brown; Friederike Schlürmann; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; David McGuinness; Arnold Degboe; Fred Saad
errShare
errSave
Multiplexed Spatial Imaging at the Single-Cell Level Reveals Mutually Exclusive Expression of B7 Family Proteins
errLABORATORY INVESTIGATION
IF4.2
err2024-10-01
err0
PREAI
errShojo, Kazunori; Tanaka, Nobuyuki; Murakami, Tetsushi; Anno, Tadatsugu; Teranishi, Yu; Takamatsu, Kimiharu; Mikami, Shuji; Imamura, Takeshi; Matsumoto, Kazuhiro; Oya, Mototsugu
errShare
errSave
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2024-08-22
err5
PREAI
errChoueiri, T. K.; Powles, T.; Peltola, K.; de Velasco, G.; Burotto, M.; Suarez, C.; Ghatalia, P.; Iacovelli, R.; Lam, E. T.; Verzoni, E.; Gumus, M.; Stadler, W. M.; Kollmannsberger, C.; Melichar, B.; Venugopal, B.; Gross-Goupil, M.; Poprach, A.; De Santis, M.; Schutz, F. A.; Park, S. H.; Nosov, D. A.; Porta, C.; Lee, J. L.; Garcia-del-Muro, X.; Biscaldi, E.; Kopp, R. Manneh; Oya, M.; He, L.; Wang, A.; Perini, R. F.; Vickery, D.; Albiges, L.; Rini, B.
errShare
errSave
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study
errJOURNAL OF IMMUNOLOGY
IF3.4
err2024-05-17
err0
errOAAI
errTanegashima, Tokiyoshi; Shiota, Masaki; Fujiyama, Nobuhiro; Narita, Shintaro; Habuchi, Tomonori; Fukuchi, Genshiro; Takamatsu, Dai; Oda, Yoshinao; Miyake, Hideaki; Takahashi, Masayuki; Oya, Mototsugu; Tsuchiya, Norihiko; Masumori, Naoya; Matsuyama, Hideyasu; Obara, Wataru; Shinohara, Nobuo; Fujimoto, Kiyohide; Nozawa, Masahiro; Ohba, Kojiro; Ohyama, Chikara; Hashine, Katsuyoshi; Akamatsu, Shusuke; Kamba, Tomomi; Mita, Koji; Gotoh, Momokazu; Tatarano, Shuichi; Fujisawa, Masato; Tomita, Yoshihiko; Mukai, Shoichiro; Ito, Keiichi; Tokunaga, Shoji; Eto, Masatoshi
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
K
Karl Deisseroth
H-index: 182 · Papers: 634
T
Toni K. Choueiri
H-index: 149 · Papers: 2.4K
R
Robert J. Motzer
H-index: 148 · Papers: 1.6K
F
Francesco Montorsi
H-index: 146 · Papers: 4.1K
S
Shahrokh F. Shariat
H-index: 146 · Papers: 2.9K
View more